Dr. Rottinghaus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
121 Seaport Boulevard
Boston, MA 02210Phone+1 475-230-3956
Education & Training
University of Alabama Medical CenterFellowship, Infectious Disease, 2004 - 2007
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2001 - 2004- Mayo Clinic College of MedicineClass of 2001
Certifications & Licensure
CT State Medical License 2007 - 2025
MN State Medical License 2002 - 2024
AL State Medical License 2004 - 2009
Publications & Presentations
PubMed
- 39 citationsPharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two...Régis Peffault de Latour, Robert A. Brodsky, Stephan Ortiz, Antonio M. Risitano, Jun H. Jang
British Journal of Haematology. 2020-11-01 - 7 citationsAssessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©).Karen Kaiser, Susan Yount, Christa E. Martens, Kimberly Webster, Sara Shaunfield
Patient Preference and Adherence. 2020-04-05 - 221 citationsRavulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study.Austin G. Kulasekararaj, Anita J. Hill, Scott T. Rottinghaus, Saskia Langemeijer, Richard A. Wells
Blood. 2019-02-07
Press Mentions
- Ethics Approval and Consent to ParticipateJuly 13th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
